earnings
confidence high
sentiment positive
materiality 0.70
Elevance Health pre-announces Q1 2025 adjusted EPS of $11.97; reaffirms FY guidance
Elevance Health, Inc.
2025-Q1 EPS reported
$9.61
revenue$48,891,000,000
- Q1 GAAP EPS of $9.61, includes $2.36/share net unfavorable items; adjusted EPS $11.97.
- Medical cost trends, including Medicare Advantage, in line with expectations during Q1.
- Reaffirms FY 2025 adjusted EPS guidance of $34.15–$34.85; Medicare Advantage membership 2,200–2,250k.
- Full Q1 results and outlook details to be released on April 22, 2025.